ASHLEY ZIEBARTH: Open Payments
NPI 1982234803 · WHITE LAKE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,046 in 54 payments from 16 companies in 2025. Trend: 2023 $1,444 · 2024 $733 · 2025 $1,046
Food & beverage: $1,039Education: $7
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 12 | $252 |
| Vanda Pharmaceuticals Inc. | 9 | $140 |
| Novo Nordisk Inc | 5 | $81 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Braeburn Inc. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Orexo US, Inc. | 3 | $64 |
| ABBVIE INC. | 2 | $49 |
| Exact Sciences Corporation | 2 | $36 |
Products named: SUBLOCADE, FANAPT, Auvelity, BRIXADI, CAPLYTA, Zubsolv, Wegovy, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
